Trials / Sponsors / Radiopharm Theranostics, Ltd
Radiopharm Theranostics, Ltd
Industry · 7 registered clinical trials — 7 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2026-03-05 |
| Recruiting | 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer, NSCLC (Non-small Cell Lung Cancer) | Phase 1 / Phase 2 | 2026-02-23 |
| Not Yet Recruiting | A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tu Imaging, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 | 2026-01-30 |
| Recruiting | HEAT Trial (HER2 Antibody Therapy With Lutetium-177) HER2 Gene Mutation, Advanced Solid Tumors | EARLY_Phase 1 | 2025-02-12 |
| Recruiting | Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases Brain Metastases From Solid Tumors | Phase 2 | 2024-12-13 |
| Recruiting | 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors PDL1 Gene Mutation, Non Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ) | EARLY_Phase 1 | 2024-06-03 |
| Recruiting | Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors Healthy Volunteers, Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2023-11-09 |